Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Susan Barry et al.|New England Journal of Medicine|2012Cited by 1.1k
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Allegra A. Petti et al.|New England Journal of Medicine|2016Cited by 783
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodríguez‐Otero, Sergio Giralt, Sikander Ailawadhi et al.|New England Journal of Medicine|2023Cited by 695
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia Wagner, Todd A. Fehniger, Maximillian Rosario et al.|Journal of Clinical Investigation|2017Cited by 311
Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Rizwan Romee, Jesse Keller et al.|Biology of Blood and Marrow Transplantation|2016Cited by 164